Autonomic Dysfunction

Blurred Boundaries: The Therapeutics and Politics of Medical Marijuana
Cannabinoid CB2 receptor activation attenuates motor and autonomic function deficits in a mouse model of spinal cord injury
* Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis
Cannabinoid pharmacology: the first 66 years
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
* Cannabinoids and experimental models of multiple sclerosis
Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta
Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries
Effects of cannabinoids on sympathetic and parasympathetic neuroeffector transmission in the rabbit heart
Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells
* The endocannabinoid system and its therapeutic exploitation
The endocannabinoid system as an emerging target of pharmacotherapy
Vascular targets for cannabinoids: animal and human studies

What are your Feelings

Still stuck? How can we help?